kidney disease

Jun 24, 2022

Almac, AstraZeneca Strike CDx Development Pact

Mar 31, 2022

Renalytix Q2 Revenues More Than Doubles, Firm Announces $30M Financing Round

Mar 29, 2022

Use of Community Resources to Inform Black Patients of Genetic Test Results Improves Outcomes, Study Finds
Premium

Jan 4, 2022

BTIG Initiates Coverage of Kidney Disease Diagnostics Firm Renalytix With Buy Rating

Dec 7, 2021

Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November

Oct 21, 2021

Renalytix Posts $1.5M in Revenues for Fiscal 2021

Apr 22, 2021

Renalytix AI Lands US Government Contract for Kidney Disease Test

Apr 14, 2021

RenalytixAI, Joslin Diabetes Center Ink Kidney Disease IP Agreement

Apr 14, 2021

Calciscon Raises $2.7M in Series A Round

Mar 29, 2021

My Health Logic Licenses Lab-On-A-Chip Technology to Develop At-Home Kidney Disease Test

Mar 19, 2021

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 16, 2021

NephroSant Raises $16M in Series A Funding Round

Mar 2, 2021

RenalytixAI Reports Q2 2021 Revenues of $400K

Feb 24, 2021

RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health

Jan 21, 2021

Numares Collaborating With Bruker on NMR-Based Diagnostics

Jan 8, 2021

RenalytixAI, DaVita Aim to Woo Payors with Chronic Kidney Disease Prevention Risk-Share Model
Premium

Jan 5, 2021

RenalytixAI, DaVita to Offer Chronic Kidney Disease Risk Assessment, Patient Management

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 3, 2020

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection